Patents by Inventor Joakim Dillner

Joakim Dillner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cells
    Publication number: 20040146531
    Abstract: The present invention relates to a carrier for introduction of substances into cells comprising a modified major capsid protein L1 of human papillomavirus (HPV-L1 protein) devoid of type-specific epitopes causing production of neutralising antibodies. The invention also includes an oligo- or polynucleotide coding for said carrier, vaccines comprising said carrier or said oligo- or polynucleotide, as well as methods of using the carrier or the oligo- or polynucleotide in vaccination against viral, bacterial or parasite infections as well as against development of certain cancers. Especially, infections of human papillomavirus and the development of cancer as a consequence of such infections are recognised.
    Type: Application
    Filed: January 20, 2004
    Publication date: July 29, 2004
    Applicant: Active Biotech AB
    Inventors: Per Antonsson, Karin Kristensson, Marie Wallen-Ohman, Joakim Dillner, Peter Lando
  • Peptide-based composition against papillomavirus infection
    Patent number: 5989548
    Abstract: Pharmaceutical compositions comprising an antigenic amount of peptides derived from the L1 and L2 OFR's of human papillomavirus type 16 coupled to a carrier or in multimer form.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: November 23, 1999
    Assignee: Euro-Diagnostica AB
    Inventor: Joakim Dillner
  • Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes
    Patent number: 5932412
    Abstract: The invention refer to a method for diagnosing the presence of infection of papilloma virus (PV) and of papilloma virus (PV) carrying, especially cervix cancer and condyloma, by the detection of virus specific antigen-antibody complexes in immunossay.
    Type: Grant
    Filed: September 22, 1997
    Date of Patent: August 3, 1999
    Assignee: Euro-Diagnostica AB
    Inventors: Joakim Dillner, Lena Dillner, Hwee-Ming Cheng
  • Method for detection of human papillomavirus (HPV) for diagnostic purposes
    Patent number: 5629146
    Abstract: Method for detection of infection with human papillomavirus (HPV) for diagnostic purposes, particularly for diagnosing carcinoma, or pre-stages thereof, or the risk of development of carcinoma. The detection is effected on a body fluid, particularly on a secretion from cervix uteri, by ascertaining the presence of IgA, IgG and IgM antibodies against papillomavirus virions, including individual virion proteins or peptides thereof, in the body fluid.
    Type: Grant
    Filed: June 25, 1991
    Date of Patent: May 13, 1997
    Assignee: Ferring AB
    Inventors: Joakim Dillner, Lena Dillner
  • Antibodies to human papillomavirus latent proteins, diagnostic systems and methods
    Patent number: 5486453
    Abstract: The present invention relates to polypeptides that immunologically mimic papillomavirus latent proteins and to antibodies and monoclonal antibodies that immunoreact with papillomavirus latent proteins. Systems and methods for detecting the presence and type of papillomavirus in a human subject are also described.
    Type: Grant
    Filed: September 17, 1993
    Date of Patent: January 23, 1996
    Assignee: The Scripps Research Institute
    Inventors: Joakim Dillner, Richard A. Lerner, Richard Smith, D. Elliot Parks
  • Antibodies to human papillomavirus latent proteins, diagnostic systems and methods
    Patent number: 5401627
    Abstract: The present invention relates to polypeptides that immunologically mimic papillomavirus latent proteins and to antibodies and monoclonal antibodies that immunoreact with papillomavirus latent proteins. Systems and methods for detecting the presence and type of papillomavirus in a human subject are also described.
    Type: Grant
    Filed: December 23, 1992
    Date of Patent: March 28, 1995
    Assignee: The Scripps Research Institute
    Inventors: Joakim Dillner, Richard A. Lerner, Richard Smith, D. Elliot Parks
  • Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods
    Patent number: 5180806
    Abstract: The present invention relates to polypeptides that immunologically mimic papillomavirus latent proteins and to antibodies and monoclonal antibodies that immunoreact with papillomavirus latent proteins. Systems and methods for detecting the presence and type of papillomavirus in a human subject are also described.
    Type: Grant
    Filed: March 13, 1989
    Date of Patent: January 19, 1993
    Assignee: The Scripps Research Institute
    Inventors: Joakim Dillner, Richard A. Lerner, Richard Smith, D. Elliot Parks